FDA Warning Letter — Rebom Co., Ltd.

Case 682811 — FEI 3013693278

The FDA took a Warning Letter action against Rebom Co., Ltd. on Jun 26, 2024 (Sejong, South Korea). The action was issued by CDER and concerns drugs products.

Action Details

Facility
Rebom Co., Ltd.
Date
Jun 26, 2024
Fiscal Year
2024
Product Type
Drugs
Center
CDER
Location
Sejong (South Korea)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.